ABRA | Actin-binding Rho activating protein | | | | | | Group enriched |
AC011239.1 | Uncharacterized protein | | | | | | Group enriched |
ACTN2 | Actinin, alpha 2 | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Group enriched |
ADPRHL1 | ADP-ribosylhydrolase like 1 | | | | | | Group enriched |
AL109927.1 | HCG2032222; PRO2047; Uncharacterized protein | | | | | | Group enriched |
AL158147.2 | HCG2011465; Uncharacterized protein | | | | | | Group enriched |
ALPK3 | Alpha-kinase 3 | Enzymes
| | | | | Group enriched |
ANKRD2 | Ankyrin repeat domain 2 (stretch responsive muscle) | | | | | | Group enriched |
APOBEC2 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2 | | | | | | Group enriched |
ARPP21 | CAMP-regulated phosphoprotein, 21kDa | | | | | | Group enriched |
ARX | Aristaless related homeobox | Disease related genes Plasma proteins Transcription factors
| | | | | Group enriched |
ASB11 | Ankyrin repeat and SOCS box containing 11 | Predicted membrane proteins
| | | | | Group enriched |
ASB15 | Ankyrin repeat and SOCS box containing 15 | | | | | | Group enriched |
ASB18 | Ankyrin repeat and SOCS box containing 18 | Predicted membrane proteins
| | | | | Group enriched |
ASB4 | Ankyrin repeat and SOCS box containing 4 | | | | | | Group enriched |
C10orf71 | Chromosome 10 open reading frame 71 | | | | | | Group enriched |
CACNG6 | Calcium channel, voltage-dependent, gamma subunit 6 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CAMK2A | Calcium/calmodulin-dependent protein kinase II alpha | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CAMK2B | Calcium/calmodulin-dependent protein kinase II beta | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CARNS1 | Carnosine synthase 1 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
CAV3 | Caveolin 3 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CKMT2 | Creatine kinase, mitochondrial 2 (sarcomeric) | Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Group enriched |
CMYA5 | Cardiomyopathy associated 5 | | | | | | Group enriched |
COQ10A | Coenzyme Q10 homolog A (S. cerevisiae) | Mitochondrial proteins
| | | | | Group enriched |
COX6A2 | Cytochrome c oxidase subunit VIa polypeptide 2 | Mitochondrial proteins Transporters
| | | | | Group enriched |
COX7A1 | Cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
CSRP3 | Cysteine and glycine-rich protein 3 (cardiac LIM protein) | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Group enriched |
DCUN1D2 | DCN1, defective in cullin neddylation 1, domain containing 2 | | | | | | Group enriched |
DDN | Dendrin | | | | | | Group enriched |
DHRS7C | Dehydrogenase/reductase (SDR family) member 7C | Predicted secreted proteins
| | | | | Group enriched |
DUSP27 | Dual specificity phosphatase 27 (putative) | | | | | | Group enriched |
FABP3 | Fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) | Candidate cardiovascular disease genes Plasma proteins
| | | | | Group enriched |
FAM166B | Family with sequence similarity 166, member B | | | | | | Group enriched |
FBXO40 | F-box protein 40 | Plasma proteins
| | | | | Group enriched |
FITM1 | Fat storage-inducing transmembrane protein 1 | Predicted membrane proteins
| | | | | Group enriched |
FSD2 | Fibronectin type III and SPRY domain containing 2 | | | | | | Group enriched |
GAMT | Guanidinoacetate N-methyltransferase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
GHR | Growth hormone receptor | Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
HFE2 | Hemochromatosis type 2 (juvenile) | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
HHATL | Hedgehog acyltransferase-like | Predicted membrane proteins
| | | | | Group enriched |
HRC | Histidine rich calcium binding protein | Predicted secreted proteins
| | | | | Group enriched |
HSPB3 | Heat shock 27kDa protein 3 | Disease related genes
| | | | | Group enriched |
IGFN1 | Immunoglobulin-like and fibronectin type III domain containing 1 | | | | | | Group enriched |
IL17D | Interleukin 17D | Predicted secreted proteins
| | | | | Group enriched |
KBTBD12 | Kelch repeat and BTB (POZ) domain containing 12 | | | | | | Group enriched |
KLHL31 | Kelch-like family member 31 | | | | | | Group enriched |
KLHL38 | Kelch-like family member 38 | | | | | | Group enriched |
LDB3 | LIM domain binding 3 | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Group enriched |
LMOD2 | Leiomodin 2 (cardiac) | Cytoskeleton related proteins
| | | | | Group enriched |
LMOD3 | Leiomodin 3 (fetal) | Cytoskeleton related proteins
| | | | | Group enriched |